Zentalis Pharmaceuticals Inc <ZNTL.O>: Mizuho initiates coverage with outperform rating; target price $8
ZNTL•Related News
Fairmount Healthcare Fund II LP acquires 853,450 Crescent Biopharma shares for $12.38 million
CBIO•
MasTec - Borrows $700 Million Under New Term Loan Agreement On July 20, 2026 - SEC Filing
MTZ•
AEP declares quarterly dividend of 95 cents a share
AEP•
New Zealand dollar firms with inflation, Aussie follows
FXA•
Technicals-CBOT soybeans may fall into $12.11-1/4 to $12.15-3/4 range
DBA•